SPOTLIGHT -
Popular HIV-1 med successful, particularly in order adults
Gilead will present new data on virologic suppression in adults 65 years and older at AIDS 2020: Virtual this week.
FDA okays novel breast, colorectal cancer treatments
Colorectal cancer drug is the first immunotherapy administered as a first-line treatment and without chemotherapy.
Major Metformin recalls underway
Five pharma markers are recalling the diabetes medication due to the presence of a carcinogenic ingredient.
Remdesivir for COVID-19 in short supply
HHS says supply could run out by the end of this month.
New antibiotic for hospital-acquired pneumonia available
The agency welcomes another option for serious bacterial infections.
Drug’s indication expanded to reduce heart attack, stroke risk
Brilinta is already approved to prevent atherothrombotic events in ASC.
Two metformin products recalled, more on the way
Immediately after the FDA said it found elevated levels of the carcinogenic ingredient N-nitrosodimethylamine (NDMA) in certain extended release (ER) metformin products, the first 2 major recalls are underway.
FDA approves med for severe malaria
IV artesunate is the only drug available in the U.S. to treat the disease.
Pharma maker recalls drug over undeclared anti-hypertensive drug
Top 3 COVID-19 stories this week
FDA authorizes first stand-alone, at-home test, plus other top COVID-19 news stories.
FDA clears new antigen, saliva tests for COVID-19
Antigen tests, a new category, have a major advantage and disadvantage over COVID-19 tests already approved.
FDA: Fraudulent COVID-19 medical products abound
Numerous PPEs and testing kits also feature unproven coronavirus claims.
New subcutaneous multiple myeloma treatment available
Formulation could cause fewer administration-related reactions than IV Darzalex.
COVID-19 vaccines could be ready this year, plus other top news
Popular heartburn medication now in shortage due to COVID-19 test.
FDA restricts hydroxychloroquine use, plus other COVID-19 updates
Agency says the anti-malaria drug can cause heart rhythm problems.
FDA warns CBD companies making medical claims
Suppliers claim CBD can help alleviate opioid addiction, cure diseases.
New lung cancer treatment launches
The drug, plus chemotherapy, shows a significant survival benefit.
FDA clears first home COVID-19 test, plus other top news
Hospitals could receive $75 billion in funding to combat coronavirus.
Another RA drug starts testing to treat COVID-19
Olumiant trial joins other RA drug trials, including hydroxychloroquine.
COVID-19 drug price skyrockets, clinical trial begins
An NIH trial on the controversial anti-malaria medication is underway.
Trump, Fauci disagree on the effectiveness of hydroxychloroquine
More COVID-19 patients receive anti-malaria drug despite controversy.
FDA authorizes treatment, rapid test for COVID-19
Agency issues Emergency Use Authorization for hydroxychloroquine sulfate, along with a novel COVID-19 test.
FDA expands hepatitis C treatment to children
Clinical trial results were similar to those of the drug in adults.
Drugmaker halts access to COVID drug as FDA approves novel test
First point-of-care test to detect coronavirus cleared.
FDA expedites coronavirus testing kits
The agency takes other steps to make COVID-19 tests more available.
FDA requires boxed warning on Singulair
New measures taken due to depression, suicidal thoughts, and other adverse events.
Top 3 Things to Know About Coronavirus Treatments
Discover the latest news on COVID-19 vaccine and drug development.
FDA, FTC warn suppliers of fraudulent COVID-19 products
Companies cited over false coronavirus claims include The Jim Bakker Show.
New multiple myeloma treatment works by targeting cells
Isatuximab-irfc (Sarclisa, Sanofi-Aventis) was approved in combination with pomalidomide and dexamethason to treat adult patients with multiple myeloma who have received at least two prior therapies.
FDA clears generic asthma inhaler, inhaled corticosteroid
Inhaler is the first generic approval of its kind.